Lamivudine 50742-0624
Product NDC
50742-0624- Manufacturer
- Ingenus Pharmaceuticals, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 1, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA206974
Need to source Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lamivudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Packaging Options(1)
30 TABLET in 1 BOTTLE, PLASTIC (50742-624-60)